Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Boye

Showing results (111-120 of 190) with videos related to

Pageof 19
Sort By:
Advances in Experimental Medicine and Biology|March 26, 2014
Cone specific promoter for use in gene therapy of retinal degenerative diseasesFrank M Dyka, Sanford L Boye, Renee C Ryals, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2011
Long-term RNA interference gene therapy in a dominant retinitis pigmentosa mouse modelLi Jiang, Houbin Zhang, Alexander M Dizhoor, et al.
Molecular Vision|November 25, 2016
Functional study of two biochemically unusual mutations in <i>GUCY2D</i> Leber congenital amaurosis expressed via adenoassociated virus vector in mouse retinasSanford L Boye, Elena V Olshevskaya, Igor V Peshenko, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 21, 2015
Gene therapy with the caspase activation and recruitment domain reduces the ocular inflammatory responseCristhian J Ildefonso, Henrique Jaime, Manas R Biswal, et al.
Human Gene Therapy|March 30, 2020
Adeno-Associated Virus D-Sequence-Mediated Suppression of Expression of a Human Major Histocompatibility Class II Gene: Implications in the Development of Adeno-Associated Virus Vectors for Modulating Humoral Immune ResponseHyung-Joo Kwon, Keyun Qing, Selvarangan Ponnazhagan, et al.
Current Biology : CB|September 30, 2022
Post-developmental plasticity of the primary rod pathway allows restoration of visually guided behaviorsYan Cao, Diego Fajardo, Debbie Guerrero-Given, et al.
Genomics|December 1, 1991
Major rearrangements in the alpha 5(IV) collagen gene in three patients with Alport syndromeE Boye, D Vetrie, F Flinter, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 10, 1985
[Are the Norwegian nuclear medicine laboratories good enough? A report from a nationwide quality control survey of nuclear medicine instruments performed by the Norwegian Society for Nuclear Medicine and the National Institute for Radiation Protection]K Rootwelt, A Skretting, T Bjørnerud, et al.
Gene Therapy|April 30, 2010
rAAV2/5 gene-targeting to rods:dose-dependent efficiency and complications associated with different promotersW A Beltran, S L Boye, S E Boye, et al.
Human Genetics|January 1, 1993
X chromosome linkage studies in familial Rett syndromeA R Curtis, S Headland, S Lindsay, et al.
Pageof 19

Showing results (111-120 of 190) with videos related to

Sort By:
Pageof 19
Advances in Experimental Medicine and Biology|March 26, 2014
Cone specific promoter for use in gene therapy of retinal degenerative diseasesFrank M Dyka, Sanford L Boye, Renee C Ryals, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2011
Long-term RNA interference gene therapy in a dominant retinitis pigmentosa mouse modelLi Jiang, Houbin Zhang, Alexander M Dizhoor, et al.
Molecular Vision|November 25, 2016
Functional study of two biochemically unusual mutations in <i>GUCY2D</i> Leber congenital amaurosis expressed via adenoassociated virus vector in mouse retinasSanford L Boye, Elena V Olshevskaya, Igor V Peshenko, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 21, 2015
Gene therapy with the caspase activation and recruitment domain reduces the ocular inflammatory responseCristhian J Ildefonso, Henrique Jaime, Manas R Biswal, et al.
Human Gene Therapy|March 30, 2020
Adeno-Associated Virus D-Sequence-Mediated Suppression of Expression of a Human Major Histocompatibility Class II Gene: Implications in the Development of Adeno-Associated Virus Vectors for Modulating Humoral Immune ResponseHyung-Joo Kwon, Keyun Qing, Selvarangan Ponnazhagan, et al.
Current Biology : CB|September 30, 2022
Post-developmental plasticity of the primary rod pathway allows restoration of visually guided behaviorsYan Cao, Diego Fajardo, Debbie Guerrero-Given, et al.
Genomics|December 1, 1991
Major rearrangements in the alpha 5(IV) collagen gene in three patients with Alport syndromeE Boye, D Vetrie, F Flinter, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 10, 1985
[Are the Norwegian nuclear medicine laboratories good enough? A report from a nationwide quality control survey of nuclear medicine instruments performed by the Norwegian Society for Nuclear Medicine and the National Institute for Radiation Protection]K Rootwelt, A Skretting, T Bjørnerud, et al.
Gene Therapy|April 30, 2010
rAAV2/5 gene-targeting to rods:dose-dependent efficiency and complications associated with different promotersW A Beltran, S L Boye, S E Boye, et al.
Human Genetics|January 1, 1993
X chromosome linkage studies in familial Rett syndromeA R Curtis, S Headland, S Lindsay, et al.
Pageof 19